Attached files
| file | filename |
|---|---|
| 10-K - 10-K-2017 - Evoke Pharma Inc | evok-10k_20171231.htm |
| EX-32.2 - EX-32.2 - Evoke Pharma Inc | evok-ex322_9.htm |
| EX-32.1 - EX-32.1 - Evoke Pharma Inc | evok-ex321_7.htm |
| EX-31.2 - EX-31.2 - Evoke Pharma Inc | evok-ex312_10.htm |
| EX-31.1 - EX-31.1 - Evoke Pharma Inc | evok-ex311_8.htm |
| EX-10.21 - EX-10.21 - Evoke Pharma Inc | evok-ex1021_515.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Evoke Pharma, Inc.
Solana Beach, California
We hereby consent to the incorporation by reference in Registration Statements on Form S-3 (No. 333-221556) and Forms S-8 (No. 333-219960, 333-211302 and 333-191518) of Evoke Pharma, Inc. of our report dated March 7, 2018, relating to the financial statements, which appears in this Annual Report on Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/ BDO USA, LLP
San Diego, California
March 7, 2018